2) HBV carriers
无症状携带者
1.
Methods:The serum IL-10 level of 54 patients who had infected with Hepatitis B,including 21 HBV carriers and 33 chronic HBV patients(12 patients with mild degree,21 patients with moderate or serious degree),were detected by ELISA.
方法:分离54例HBV感染者临床血清标本,其中无症状携带者21例,慢性乙肝患者33例(轻度12例,中、重度21例)。
2.
Methods:The serum IL-2、IFN-γ and IL-10 level of 63 patients who had infected with Hepatitis B,including 21 HBV carriers and 42 chronic HBV patients(21 patients with mild degree,21 patients with moderate or serious degree)were detected by ELISA.
方法:分离63例HBV感染者血清(无症状携带者组21例,慢性乙肝患者轻度组和中、重度组各21例),双抗体夹心法ELISA定量检测血清的IL-10、IFN-γ及IL-2表达水平,10例健康献血者为对照组。
3) Healthy carriers with HBsAg
无症状HBsAg携带者
4) chromic asymptomatic HBV HBeAg positive
无症状HBeAg携带者
5) HBV carrier
HBV携带者
1.
Study on MCT syndrome types of HBV carrier in second health condition;
亚健康状态HBV携带者中医证候特点研究
2.
Objective To investigate the effects of anti-hepatitis B placenta transfer factor on HBV carrier and reveal the underlying mechanisms.
目的观察泰来肽治疗HBV携带者的临床疗效及其可能作用机制。
3.
METHODS 217 patients with tuberculosis were divided into HRZE(S) and HLAMKO treatment groups, liver function tests were monitored once2 weeks before and after the treatments, and the hepatotoxicity of 47 HBV carriers was assessed during anti tuberculosis therapy.
方法 选择肺结核患者 2 17例 ,随机分成 HRZE(S)和 HL AMKO两个治疗组 ,于治疗前和治疗后每 2 wk检测肝功能 ,并观察临床症状 ,比较两种化疗方法对肝功能的影响 ;同时分析 4 7例合并 HBV携带者肝功能的变化 。
6) Hepatitis B Vaccine/Therapeutic Use
慢性无症状携带者
补充资料：无症状乙型肝炎病毒携带者
无症状乙型肝炎病毒携带者
asymptomatic carriers hepatitis B virus
体内携带有乙型肝炎病毒但不发病者。临床无肝炎症状及体征，化验检查除HBsAg阳性外均正常。无症状乙型肝炎病毒携带者是乙型肝炎重要的传染源。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条